Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edgar G Engleman

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Seminars in Oncology|July 26, 2003
Dendritic cell-based cancer immunotherapyEdgar G Engleman
Clinical Immunology (Orlando, Fla.)|February 14, 2003
Induction of immunity to tumor-associated antigens following dendritic cell vaccination of cancer patientsEdgar G Engleman, Lawrence Fong
Methods in Molecular Biology (Clifton, N.J.)|September 19, 2007
Breaking self-tolerance to tumor-associated antigens by in vivo manipulation of dendritic cellsInes Mende, Edgar G Engleman
Oncotarget|October 13, 2015
Tumor-binding antibodies and tumor immunityYaron Carmi, Edgar G Engleman
Annals of the New York Academy of Sciences|January 6, 2006
Breaking tolerance to tumors with dendritic cell-based immunotherapyInes Mende, Edgar G Engleman
Science'S STKE : Signal Transduction Knowledge Environment|July 15, 2004
Using signaling pathways to overcome immune tolerance to tumorsEdgar G Engleman, Joshua Brody, Luis Soares
Trends in Cell Biology|May 6, 2023
Lymph nodes: at the intersection of cancer treatment and progressionNathan E Reticker-Flynn, Edgar G Engleman
Nature|January 27, 2019
A gut punch fights cancer and infectionNathan E Reticker-Flynn, Edgar G Engleman
Oncoimmunology|October 25, 2019
Tumor-binding antibodies induce potent dendritic cell-mediated tumor immunityYaron Carmi, Tyler Prestwood, Edgar G Engleman
Annual Review of Pathology|November 16, 2020
Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and ResistanceSreya Bagchi, Robert Yuan, Edgar G Engleman
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Seminars in Oncology|July 26, 2003
Dendritic cell-based cancer immunotherapyEdgar G Engleman
Clinical Immunology (Orlando, Fla.)|February 14, 2003
Induction of immunity to tumor-associated antigens following dendritic cell vaccination of cancer patientsEdgar G Engleman, Lawrence Fong
Methods in Molecular Biology (Clifton, N.J.)|September 19, 2007
Breaking self-tolerance to tumor-associated antigens by in vivo manipulation of dendritic cellsInes Mende, Edgar G Engleman
Oncotarget|October 13, 2015
Tumor-binding antibodies and tumor immunityYaron Carmi, Edgar G Engleman
Annals of the New York Academy of Sciences|January 6, 2006
Breaking tolerance to tumors with dendritic cell-based immunotherapyInes Mende, Edgar G Engleman
Science'S STKE : Signal Transduction Knowledge Environment|July 15, 2004
Using signaling pathways to overcome immune tolerance to tumorsEdgar G Engleman, Joshua Brody, Luis Soares
Trends in Cell Biology|May 6, 2023
Lymph nodes: at the intersection of cancer treatment and progressionNathan E Reticker-Flynn, Edgar G Engleman
Nature|January 27, 2019
A gut punch fights cancer and infectionNathan E Reticker-Flynn, Edgar G Engleman
Oncoimmunology|October 25, 2019
Tumor-binding antibodies induce potent dendritic cell-mediated tumor immunityYaron Carmi, Tyler Prestwood, Edgar G Engleman
Annual Review of Pathology|November 16, 2020
Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and ResistanceSreya Bagchi, Robert Yuan, Edgar G Engleman
Pageof 11